The North America Medical Radiation Detection Market would witness market growth of 7.2% CAGR during the forecast period (2023-2029).
Medical radiation detection, monitoring, and safety systems offer the necessary protections against radiation exposure for patients and healthcare personnel, allowing a safe environment or treatment with few hazards. It now forms a part of contemporary medical care. System restrictions and design requirements should be followed while using medical radiation detection, monitoring, and safety equipment. The need for safety equipment is expanding along with people's awareness of the negative impacts of a radiation-prone environment.
The need for medical radiation detectors is driven by the rising incidence of cancer, which is driving market expansion. In the upcoming years, greater usage of nuclear medicine & radiation therapy for evaluating and managing acute radiation disease will also aid in expanding the medical radiation detection market. A further factor driving the market growth during the projection period is the rising number of diagnostic imaging facilities that need medical radiation detectors to prevent excessive radiation exposure.
Furthermore, the medical radiation detection market would experience expansion during the projected period due to growing awareness regarding the dangers of prolonged radiation exposure, particularly in radiation-prone environments, and a rise in the number of people with health insurance. Additionally, it is anticipated that the business will benefit from the expanded potential for medical radiation detection in growing markets in the upcoming years.
Cancer continues to be the primary cause of mortality in Canada. Approximately 40% of the Canadian population is projected to receive a cancer diagnosis during their lifetime, with approximately 25% of those individuals succumbing to the disease. In 2021, it is projected that there will be 229,200 cancer diagnoses and 84,600 cancer-related deaths in Canada. Hence, the medial radiation detection market growth in the region is expected to be driven by the increased utilization of nuclear medicine and radiation therapy for diagnosis and treatment, due to the rise in the number of individuals with cancer.
The US market dominated the North America Medical Radiation Detection Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $400.1 million by 2029. The Canada market is poised to grow at a CAGR of 9.6% during (2023 - 2029). Additionally, The Mexico market would witness a CAGR of 8.6% during (2023 - 2029).
Based on Product, the market is segmented into Personal Dosimeters, Area Process Dosimeters, Surface Contamination Monitors and Others. Based on Type, the market is segmented into Gas-filled Detectors, Scintillators and Solid-state. Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgical Centers, Diagnostic Imaging Centers and Homecare. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Medical Radiation Detection Market is Projected to reach USD 1.5 Billion by 2029, at a CAGR of 7.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IBA Dosimetry GmbH, Mirion Technologies, Inc., Thermo Fisher Scientific, Inc., LANDAUER (Fortive Corporation), Polimaster Europe UAB, PTW Freiburg GmbH, ATOMTEX, Radiation Detection Company, MP Biomedicals, LLC (Valiant Co. Ltd), and Amray Group Ltd.
By Product
By Type
By End Use
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 